Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Akimoto

Showing results (121-130 of 237) with videos related to

Pageof 24
Sort By:
The Prostate|January 1, 1987
Modalities of chemotherapy and endocrine therapy for growth inhibition of androgen-stimulated mouse carcinoma (Shionogi carcinoma 115)S Hara, T Ichikawa, S Akimoto, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 1, 1988
[Treatment of prostatic cancer with slow-release formulation of luteinizing hormone releasing hormone (LH-RH) analog]H Fuse, S Akimoto, K Akakura, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|July 1, 1992
[Relationship between extent of bone metastases and effect of endocrine therapy evaluated with bone scintigraphy in stage D2 prostatic cancer]M Tanaka, S Murakami, S Akimoto, et al.
Hinyokika Kiyo. Acta Urologica Japonica|May 1, 1992
Inverted papilloma of the renal pelvis associated with renal cell carcinoma: a case reportT Ueda, S Akimoto, J Shimazaki, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|April 6, 2006
Water chemistry gradient in a degraded bog areaR Iqbal, S Akimoto, K Tokutake, et al.
The Prostate|February 11, 1999
Inability of bone turnover marker as a strong prognostic indicator in prostate cancer patients with bone metastasis: comparison with the extent of disease (EOD) gradeS Akimoto, Y Furuya, K Akakura, et al.
Hinyokika Kiyo. Acta Urologica Japonica|November 1, 1994
[Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer]S Akimoto, T Ohki, T Ichikawa, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|January 1, 1988
[Endocrine therapy of stage D2 prostatic carcinoma]S Akimoto, K Akakura, H Fuse, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 26, 1998
Influence of osteoarthritis on serum marker levels of bone formation and resorption in patients with benign prostatic hypertrophyS Akimoto, Y Furuya, K Akakura, et al.
Advances in Experimental Medicine and Biology|January 1, 1992
Clinical course of bone metastasis from prostatic cancer following endocrine therapy: examination with bone x-rayJ Shimazaki, T Higa, S Akimoto, et al.
Pageof 24

Showing results (121-130 of 237) with videos related to

Sort By:
Pageof 24
The Prostate|January 1, 1987
Modalities of chemotherapy and endocrine therapy for growth inhibition of androgen-stimulated mouse carcinoma (Shionogi carcinoma 115)S Hara, T Ichikawa, S Akimoto, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 1, 1988
[Treatment of prostatic cancer with slow-release formulation of luteinizing hormone releasing hormone (LH-RH) analog]H Fuse, S Akimoto, K Akakura, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|July 1, 1992
[Relationship between extent of bone metastases and effect of endocrine therapy evaluated with bone scintigraphy in stage D2 prostatic cancer]M Tanaka, S Murakami, S Akimoto, et al.
Hinyokika Kiyo. Acta Urologica Japonica|May 1, 1992
Inverted papilloma of the renal pelvis associated with renal cell carcinoma: a case reportT Ueda, S Akimoto, J Shimazaki, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|April 6, 2006
Water chemistry gradient in a degraded bog areaR Iqbal, S Akimoto, K Tokutake, et al.
The Prostate|February 11, 1999
Inability of bone turnover marker as a strong prognostic indicator in prostate cancer patients with bone metastasis: comparison with the extent of disease (EOD) gradeS Akimoto, Y Furuya, K Akakura, et al.
Hinyokika Kiyo. Acta Urologica Japonica|November 1, 1994
[Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer]S Akimoto, T Ohki, T Ichikawa, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|January 1, 1988
[Endocrine therapy of stage D2 prostatic carcinoma]S Akimoto, K Akakura, H Fuse, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 26, 1998
Influence of osteoarthritis on serum marker levels of bone formation and resorption in patients with benign prostatic hypertrophyS Akimoto, Y Furuya, K Akakura, et al.
Advances in Experimental Medicine and Biology|January 1, 1992
Clinical course of bone metastasis from prostatic cancer following endocrine therapy: examination with bone x-rayJ Shimazaki, T Higa, S Akimoto, et al.
Pageof 24